IP Library › Assignment 037273/0311
Patent Assignment
Reel/Frame 037273/0311

Assignment of Assignor's Interest

Recorded: 2015-12-11 Pages: 17
Assignor
Assignee
CENTREXION THERAPEUTICS CORPORATION
509 SOUTH EXETER STREET, BALTIMORE, MARYLAND, 21202
Covered Property (1)
New CCR2 Receptor Antagonists and Uses Thereof
Patent: 9,670,222 →
Application: 14/260,552 →
Publication: US 2014/0235661
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 11, 2015
From: EBEL, HEINER, MR.; FRATTINI, SARA, MS.; GERLACH, KAI, MR.; GIOVANNINI, RICCARDO, MR.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 037273/0285 →
Security Interest Jul 12, 2023
From: CENTREXION THERAPEUTICS CORPORATION
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 064256/0125 →
Release of Security Interest Nov 21, 2025
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 073683/0099 →
Security Interest Nov 21, 2025
From: CENTREXION THERAPEUTICS CORPORATION
To: ANKURA TRUST COMPANY, LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 073683/0108 →